Home

Market Capitalization of Medicamen Biotech Ltd

Image

Medicamen Biotech Ltd

NSE: MEDICAMEQ

Market Cap

₹ 695.81 crore

Last updated on: Feb 21, 2025

Key Highlights

  • The Market Cap of Medicamen Biotech Ltd is ₹ 695.81 crore as of 21 Feb 25 .
  • The Latest Trading Price of Medicamen Biotech Ltd is ₹ 547.25 as of 21 Feb 15:30 .
  • The dividend payouts of Medicamen Biotech Ltd changed from ₹ 1 to ₹ 1 over 6 quarters. This represents a CAGR of 0.00% .
Image

Medicamen Biotech Ltd

NSE: MEDICAMEQ

Share Price

₹ 547.25

20.30 (3.85%)

stock direction

Last updated on: Feb 21, 2025

Market Price of Medicamen Biotech Ltd

1M

1Y

3Y

5Y

Monitoring Medicamen Biotech Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
21 Feb 2025547.25
20 Feb 2025526.95
19 Feb 2025498.35
18 Feb 2025466.35
17 Feb 2025449.8
14 Feb 2025430.65
13 Feb 2025469.6
12 Feb 2025466.55
11 Feb 2025472
10 Feb 2025496.85

SWOT Analysis Of Medicamen Biotech Ltd

Strength

4

che

Weakness

0

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Medicamen Biotech Ltd

Asset Value vs Market Value of Medicamen Biotech Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of Market Cap

Key Valuation Metric of Medicamen Biotech Ltd

No data available

No data available

Historical P/E Ratio of Medicamen Biotech Ltd

No data available

* All values are in %

Historical Revenue of Medicamen Biotech Ltd

No data available

* All values are in crore

Historical EBITDA of Medicamen Biotech Ltd

No data available

* All values are in crore

Historical Net Profit of Medicamen Biotech Ltd

No data available

* All values are in crore

Historical Dividend Payouts of Medicamen Biotech Ltd

No data available

* All values are in

About Medicamen Biotech Ltd

  • A diversified enterprise, Medicamen Biotech Limited (MBL) is a research-led pharmaceutical company involved in developing, manufacturing and marketing of finished dosage formulations for domestic as well as international markets.
  • The Company has presence in 40+ countries.
  • Its offerings include Finished Dosage Forms (FDF's) to African countries. In India, MBL is among the leading companies in oncology segment with its own sales force and a branding team that has helped garner a strong foothold in the domestic market.
  • MBL has three pharma formulation facilities including two in Haridwar (Uttarakhand), one in Bhiwadi (Rajasthan).
  • The Company manufactures products across various therapeutic categories including Pain Management, Cough & Cold, Cardiovascular & Central Nervous System, Anti-Diabetic, Gastrointestinal, Anti-Allergic among others.

Medicamen Biotech Ltd News Hub

Medicamen Biotech consolidated net profit declines 67.70% in the June 2024 quarter

Net profit of Medicamen Biotech declined 67.70% to Rs 1.35 crore in the quarter ended June 2024 as a

Read more

13 Aug 24

Medicamen Biotech to conduct board meeting

Medicamen Biotech will hold a meeting of the Board of Directors of the Company on 13 August 2024. Po

Read more

12 Aug 24

Medicamen Biotech to conduct AGM

Medicamen Biotech announced that the Annual General Meeting (AGM) of the company will be held on 26

Read more

13 Sept 24

Medicamen Biotech declare Quarterly Result

Medicamen Biotech will hold a meeting of the Board of Directors of the Company on 14 November 2024 P

Read more

08 Nov 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Medicamen Biotech Ltd Market Cap

What is the market cap of Medicamen Biotech Ltd?

As of February 22, 2025, Medicamen Biotech Ltd has a market capitalization of ₹695.81, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Medicamen Biotech Ltd's market capitalization?

Medicamen Biotech Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Medicamen Biotech Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Medicamen Biotech Ltd's market capitalization change?

Medicamen Biotech Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions